| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/22/2004 | WO2004033717A9 Autism gene |
| 07/22/2004 | WO2004033629A3 Reverse transcription on microarrays |
| 07/22/2004 | WO2004033485A3 Nucleic acid supported protein complementation |
| 07/22/2004 | WO2004029617A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
| 07/22/2004 | WO2004029289A3 Analysis of the hla class i genes and susceptibility to type i diabetes |
| 07/22/2004 | WO2004024884A3 Syts as modifiers of the p21 pathway and methods of use |
| 07/22/2004 | WO2004023143A8 Analytical platform and identification method |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004020654A3 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 07/22/2004 | WO2004018711A3 Diagnostic test |
| 07/22/2004 | WO2004016813A3 Hnf1 alpha as a tumor suppressor gene, and diagnostic and therapeutic applications thereof |
| 07/22/2004 | WO2004015391A9 Mass spectrometry-based identification of proteins |
| 07/22/2004 | WO2004011602A3 Detection of bacterial kidney disease |
| 07/22/2004 | WO2004010102A3 Impedance based apparatuses and methods for analyzing cells and particles |
| 07/22/2004 | WO2004007547A3 Truncated tau proteins |
| 07/22/2004 | WO2004005529A3 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 07/22/2004 | WO2004001062A3 Multiplex nucleic acid reactions |
| 07/22/2004 | WO2003104762A3 Protein micro-arrays and multi-layered affinity interaction detection |
| 07/22/2004 | WO2003098661A3 Chemical and biological hazard sensor system and methods thereof |
| 07/22/2004 | WO2003097853A3 Method of screening anti-bacterial agents for effectiveness in treating persistent intracellular infections |
| 07/22/2004 | WO2003095973A3 Nanoparticle probes with raman spectroscopic fingerprints for analyte detection |
| 07/22/2004 | WO2003085084A3 Hepatitis c virus sub-genomic replicons |
| 07/22/2004 | WO2003085083A3 Liver necrosis predictive genes |
| 07/22/2004 | WO2003081202A3 Bioconjugate-nanoparticle probes |
| 07/22/2004 | WO2003078965A3 System and method for measurement of a response of localized cellular compartments |
| 07/22/2004 | WO2003077863A3 Method for overexpression of zwitterionic polysaccharides |
| 07/22/2004 | WO2003076037A3 Selective elution of immobilized multiplexed primer extension products |
| 07/22/2004 | WO2003073350A8 Method and analytical system for identifying targets in a signaling network |
| 07/22/2004 | WO2003072819A3 Analysis of mixtures of nucleic acid fragments and of gene expression |
| 07/22/2004 | WO2003059148A3 Gene expression profiles in stomach cancer |
| 07/22/2004 | WO2003057901A3 Method for detecting nucleic acid molecules based on the relative movement of surfaces |
| 07/22/2004 | WO2003053215A3 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 07/22/2004 | WO2003052078A3 Insect g protein-coupled receptor genes and uses thereof |
| 07/22/2004 | WO2003045310A9 Digital assay |
| 07/22/2004 | WO2003044511A3 Construction and use of micro-electrode arrays |
| 07/22/2004 | WO2003031463A3 14081, a human trypsin-like serine protease family member and uses therefor |
| 07/22/2004 | WO2003020118A3 Diagnosis and treatment of vascular disease |
| 07/22/2004 | WO2003014299A3 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2003010506A3 Combined electronic-and photonic-based hybridation assay |
| 07/22/2004 | WO2003010326A3 Parallel, antiparallel, homologous or complementary binding of nucleic acids |
| 07/22/2004 | WO2002102232A3 A novel signaling pathway for the production of inflammatory pain and neuropathy |
| 07/22/2004 | WO2002099048A3 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2002074239A3 Compositions and methods for the treatment and clinical remission of psoriasis |
| 07/22/2004 | US20040143864 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 07/22/2004 | US20040143858 Protein associated with phagocytic cells for use as tools in characterizing immune response |
| 07/22/2004 | US20040143854 Using inducible vectors to transform cells and propagate organism for use as drug screening tools; phenotyping |
| 07/22/2004 | US20040143112 Immunomodulatory oligonucleotides |
| 07/22/2004 | US20040143110 Comprises nucleotide sequences for use as diagnostic tools in identifying allelic sequences associated with blood sugar defects |
| 07/22/2004 | US20040143109 Nucleotide sequences for diagnosing periodontal diseases |
| 07/22/2004 | US20040143102 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 07/22/2004 | US20040143095 for treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety; angiogenesis inhibitors; genetic engineering |
| 07/22/2004 | US20040142899 Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals |
| 07/22/2004 | US20040142891 Genes involved in immune related responses observed with asthma |
| 07/22/2004 | US20040142886 use of vascular endothelial growth factor to enhance smooth muscle cell proliferation and to treat diseases associated with reduced smooth muscle cell proliferation |
| 07/22/2004 | US20040142863 modified aggrecanases, nucleotides encoding such enzymes, and processes for producing these enzymes with improved stability; treatment of osteoarthritis |
| 07/22/2004 | US20040142493 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 07/22/2004 | US20040142469 Nucleotide sequences comprising unmethylated cytosine and guaninedinucleotides for use as antisense tools in treatment and prevention of viral diseases; viricides |
| 07/22/2004 | US20040142463 Methods, compositions, and automated systems for separating rare cells from fluid samples |
| 07/22/2004 | US20040142460 Raised surface assay plate |
| 07/22/2004 | US20040142451 one linker, a biomolecule coupled to the linker, and cyclohexane derivatives |
| 07/22/2004 | US20040142449 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 07/22/2004 | US20040142440 Seryl transfer RNA synthetase polynucleotides and polypeptides and methods of use thereof |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142413 Isolated genome of xyllela fastidiosa and uses thereof |
| 07/22/2004 | US20040142412 Method for identifying <I>listeria</I> <I>monocytogenes </I> and culture medium |
| 07/22/2004 | US20040142411 Biological assays using gradients formed in microfluidic systems |
| 07/22/2004 | US20040142410 Using fluorescence polarization to identify glucuronosyltransferases involved in xenobiotic transformations; enzyme assays |
| 07/22/2004 | US20040142409 Motion sensor for monitoring migration, vibrational movement, oscillations and fluctuation in semen, ear cilia, bacteria and kinesins |
| 07/22/2004 | US20040142408 Device and method for monitoring leukocyte migration |
| 07/22/2004 | US20040142407 Assay for detecting inhibitors of the enzyme mueloperokidase |
| 07/22/2004 | US20040142406 Method of colorimetry and reagent for use therein |
| 07/22/2004 | US20040142405 Method of detecting drug resistance |
| 07/22/2004 | US20040142404 Designing cyclic peptide which modulates tyrosine kinase activity and can be used as potential treatment for asthma, eczema, food allergies, cancer, inflammatory bowel and autoimmune diseases; enzyme inhibitors |
| 07/22/2004 | US20040142403 Using minimally invasive or noninvasive diagnostic means to determine/detect defects in glucose tolerance; blood sugar profile |
| 07/22/2004 | US20040142401 Using coupled enzyme reaction system comprising acetate kinase, glucokinase, glucose-6-phosphate dehydrogenase, diaphorase and chromogen to determine concentration of adenosine triphosphate; colorimetric analysis |
| 07/22/2004 | US20040142394 Method for diagnosing a tumor in a patient determining the concentration of PIBF |
| 07/22/2004 | US20040142391 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with RAGE |
| 07/22/2004 | US20040142388 Method for detecting chronic dementia diseases, and corresponding VGF peptides and detection reagents |
| 07/22/2004 | US20040142386 Using laser excited fluorescence correlation spectroscopy to characterize and identify one or more small moleculecules in fluids |
| 07/22/2004 | US20040142383 Using proteolytic digestion to generate cleavage peptide profile and using pattern to classify source of biological material |
| 07/22/2004 | US20040142376 Deoxyribonuclease IIbeta proteins and cDNAs |
| 07/22/2004 | US20040142373 Measuring genome wide changes in gene expression profiles under various conditions; monitoring transcriptional alterations using high throughput assay; microarray analysis |
| 07/22/2004 | US20040142369 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample |
| 07/22/2004 | US20040142368 Method of identifying therapeutic agents |
| 07/22/2004 | US20040142362 Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 07/22/2004 | US20040142360 of angiotensin converting enzyme (ACE); comprise amplifying DNA from the sample with a first pair of primers that hybridize to nucleic acid sequences flanking a variant-specific gene sequence; kits |
| 07/22/2004 | US20040142359 Methods and compositions for treating neurological disorders |
| 07/22/2004 | US20040142355 Methods, compositions and libraries pertaining to PNA dimer and PNA oligomer synthesis |
| 07/22/2004 | US20040142354 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 07/22/2004 | US20040142353 Compositions and methods for identifying plants having increased tolerance to imidazolinone herbicides |
| 07/22/2004 | US20040142351 Associative analysis of gene expression array data |
| 07/22/2004 | US20040142350 Nucleic acid molecule set for detecting Salmonella, nucleic acids, kit and use |
| 07/22/2004 | US20040142349 kit for detecting a risk of cancer, coronary or cerebrovascular disease, hypertension, type 2 diabetes, dementia, joint arthrosis, cataract, or sensitivity to organophosphorus compounds |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142347 Mitochondrial DNA autoscoring system |
| 07/22/2004 | US20040142345 Methods of screening test compounds using GADD34L, an eIF2alpha-specific phosphatase subunit |
| 07/22/2004 | US20040142344 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 07/22/2004 | US20040142343 can be used to raise an antibody or a binding portion thereof; may be used alone or combined with a pharmaceutically-acceptable carrier to induce a passive immunity |
| 07/22/2004 | US20040142340 comprising an array which has immobilised oligonucleotides represented on a surface support, wherein the oligonucleotides represented have a reactive-OH group at their free 3' end, and a means of extending said 3'-OH group; solid phase synthesis |